Patient Case Discussion in Type 2 Diabetes

  • Upload
    natnael

  • View
    214

  • Download
    0

Embed Size (px)

Citation preview

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    1/25

    Patient Case Discussioin Type 2 Diabetes

    What Intensifcation Plan is Best?

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    2/25

    Outline

    Introduction Diagnostic Criteria

    Treatment Goals

    Intensifcation Guidelines Changes in i!estyle and "#ercise$

    Oral %gents$

    Basal Insulin %nalogs$

    Insulin Intensifcation

    Case Presentations

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    3/25

    Introduction

    Type 2 Diabetes &ellitus 'De!n??(

    Important to stay ) step aheado! T2D&$

    Intensi!ying antihyperglycemictherapy re*uires+

    Guideline recommendations '%D%

    , %%C"($ -a!e and e.ecti/e plans based on

    indi/idual cases$

    Intensifcation in order to meetcertain goal$

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    4/25

    Introduction

    Diabetes is not a*uic1 f#$ egular !ollo34ups

    needed$

    Treatment adherence

    is crucial$ Discuss goals o!treatment$

    "ducate patients$

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    5/25

    Diagnostic criteria

    6asting Plasma Glucose$ Impaired 6asting Glucose$

    Impaired Glucose Tolerance$

    Plasma Glucose$

    Glycated 7emoglobin$

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    6/25

    Treatment Goals+ 9onpregnant %'Out Patient(

    Parameter Treatment Goal

    %)C ':(

    Indi/iduali;e on the basis o! age$8 !or most Closer to normal !or healthy ess stringent !or @less healthyA

    6PG 'mgd( ))

    247our PPG 'mgd( )5

    FPG = fasting plasma glucose; PPG = postprandial glucose.

    Pro/ided target can be sa!ely achie/ed$

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    7/25

    Treatment Goals+ Pregnant Wome'Out Patient(

    Condition Treatment Goal

    Gestational diabetes mellitus (GDM)

    Preprandial glucose< mgd =E8

    )47our PPG< mgd =)5

    247our PPG< mgd =)2

    Preexisting T1D or T2D

    Premeal< bedtime< and o/ernight glucose4EE

    Pea1 PPG< mgd )4)2E

    %)C =>$:

    FPG = fasting plasma glucose; PPG = postprandial glucose.

    Pro/ided target can be sa!ely achie/ed$

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    8/25

    Treatment Goals+ 9onpregnant %'In Patient(

    Hospital Unit Treatment Goal

    Intensive!riti!al !are

    Glucose range< mgd )54)

    General medi!ine and surger"# non$ICU

    Premeal glucose< mgd )5

    andom glucose< mgd )

    ICU = intensive care unit.

    Pro/ided target can be sa!ely achie/ed$

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    9/25

    Intensifcation Guidelines

    Is a principle 3hichemphasi;e patient should betreated based on+

    %ge

    Degree o! complication

    Other co4morbid conditions Intensifcati

    on Therapy

    i!estyleChange

    and"#ercise

    %Oral %gents

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    10/25

    Changes in i!estyle and "#ercis

    i!estylemanagement is anintegral part o! T2D&management$

    ealistic plan !or dietand physical acti/ityis necessary$

    0

    2

    4

    !

    "0

    "2

    4.!

    #.!

    Intensive lifestyle

    intervention*

    (n=1079)

    T2DMi

    ncidence

    per100person-years

    Metfor"in

    !#0 "$ %ID

    (n=107&)

    #!'

    &1'

    $Goal% #& reduction in 'aseline 'od( )eig*t t*roug* lo)+calorie, lo)+fat diet and -"0 min/)ee modera

    PP, ia'etes Prevention Program; IG3, impaired glucose tolerance; 32, t(pe 2 dia'etes.

    PP esearc* Group. N Engl J Med. 2002;54%565+405.

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    11/25

    Oral %gents

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    12/25

    Oral %gentsClass Primar" Me!%anism o& '!tion 'gent(s) 'vailable as

    4Glucosidase

    inhibitors

    Delay carbohydrate

    absorption !rom intestine

    %carbose

    &iglitol

    Precose or gen

    Glyset

    %mylin analogue

    Decrease glucagon secretion

    -lo3 gastric emptying

    Increase satiety

    Pramlintide -ymlin

    Biguanide

    Decrease 7GP

    Increase glucose upta1e in

    muscle

    &et!orminGlucophage orgeneric

    Bile acidse*uestrant

    Decrease 7GP?

    Increase incretin le/els?Colese/elam WelChol

    DPP45 inhibitors Increase glucose4dependent

    insulin secretion

    Decrease glucagon secretion

    %logliptininagliptin-a#agliptin-itagliptin

    9esinaTradHentaOngly;aanu/ia

    Dopamine42agonist

    %cti/ates dopaminergic

    receptors

    Bromocriptine

    Cycloset

    Glinides Increase insulin secretion9ateglinideepaglinide

    -tarli# or generPrandin

    "2

    PP+4 = dipeptid(l peptidase; 7GP = *epatic glucose production.

    Gar'er 89, et al. Endocr Pract. 20"5;"6:suppl 2%"+4!. In, et al. Diabetes Care. 20"2;5%"54+"5#6.

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    13/25

    Oral %gentsClass Primar" Me!%anism o& '!tion 'gent(s) 'vailable as

    GP4) receptoragonists

    Increase glucose4dependent

    insulin secretion Decrease glucagon secretion

    -lo3 gastric emptying

    Increase satiety

    %lbiglutide

    Dulaglutide"#enatide"#enatide Jiraglutide

    Tan;eum

    TrulicityByettaBydureonKicto;a

    -GT2 inhibitors Increase urinary e#cretion o!

    glucose

    CanagliLo;inDapagliLo;in"mpagliLo;in

    In/o1ana6ar#igaardiance

    -ul!onylureas Increase insulin secretion

    GlimepirideGlipi;ideGlyburide

    %maryl or geneGlucotrol orgeneric

    Diaeta< Glyna

    &icronase< orgeneric

    Thia;olidinediones

    Increase glucose upta1e in

    muscle and !at

    Decrease 7GP

    Pioglita;oneosiglita;one

    %ctos%/andia

    "5

    G?P+" = glucagon+lie peptide; 7GP = *epatic glucose production; G?32 = sodium glucose cotransporter 2.

    Gar'er 89, et al. Endocr Pract. 20"5;"6:suppl 2%"+4!. In, et al. Diabetes Care. 20"2;5%"54+"5#6.

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    14/25

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    15/25

    Intensifcation Plan+ &ono< Dual< anTriple Therapy !or T2D&

    "

    8GI = +glucosidase in*i'itors; @C+A = 'romocriptine Buic release; Coles = colesevelam; PP4I = dipeptid(l peptidase 4 in*i'itors;G?P"8 = glucagon+lie peptide " receptor agonists; et = metformin; G?32I = sodium+glucose cotransporter 2 in*i'itors; U =sulfon(lureas; 3D = t*ia

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    16/25

    Basal Insulin %nalogs

    DoesnRt ha/e to be permanent$ -a!e and e.ecti/e$

    But o/erly aggressi/e hypoglycemia$

    7ypoglycemia Cogniti/e , psychological changes$

    %ccidents , !alls$ CK ".ects$

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    17/25

    Pharmaco1inetics o! Insulin'gent

    +nset(%)

    Pea, (%)Duration

    (%)Considerations

    -asal

    9P7 245 54) )4)> Greater ris1 o! nocturnal hypoglyce

    to insulin analogs

    GlargineDetemir

    S)45 9o pronouncedpea1

    p to 25N ess nocturnal hypoglycemia comp

    -asal$

    Prandial

    egular 48 =$8 S240 )2425 InHect 0 min be!ore a meal Indicated !or highly insulin res

    indi/iduals se caution 3hen measuring d

    inad/ertent o/erdose

    Prandial

    egular S$84) S240 p to &ust be inHected 0458 min be InHection 3ith or a!ter a meal c

    ris1 !or hypoglycemia

    %spartGlulisineisproInhaled insulin

    $8 S$842$8 S048 Can be administered 4)8 min ess ris1 o! postprandial hypog

    compared to regular insulin

    $ >1*i'its a pea at *ig*er dosages.

    E ose+dependent.

    P7, eutral Protamine 7agedorn.og*issi > et al. Endocr Pract. 20"5;"6%2+5. 7umulin U+00 :concentrated insulin prescri'ing information. Indianapolis% ?ill( U8, ??C.

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    18/25

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    19/25

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    20/25

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    21/25

    Case Discussion )

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    22/25

    Case Discussion 2 54year old 7ispanic 3oman comes to her doctor

    recommendations about her 3eight$ -he is married<

    2 children in school and 3or1s !ull time as a boo11ee-he eats brea1!ast and dinner at home< and buys luat /arious locations$

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    23/25

    Case Discussion 0ohn is a 88 year4old Caucasian man 3ith diabet

    and asthma$ 7e teaches math at a local high schoin 9e3 or1 City$ 7e 3as diagnosed 3ith typediabetes on blood tests per!ormed 3hen he appli!or li!e insurance at age 8)$ %t the time< he 3obese< 3eighing 22 pounds at 8 !eet< ) inch

    height 'B&I U 0)$>($ With 7b%)c le/el o! F$2:$

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    24/25

    e!erences

    Management of hyperglycemia in type 2 diabetepatient-centered approachV Diabetes care< /olum0854)0V -il/io "$In;ucchi

    Patient case discussions in TD: what intensicatiis best?V&edscape educationV uingi 6$&eneghin

  • 7/26/2019 Patient Case Discussion in Type 2 Diabetes

    25/25